While the abortion access landscape has shifted dramatically in recent years, brick-and-mortar clinics continue to play a critical role in both procedural and medication abortion provision. In the first half of 2025, such clinics accounted for approximately 80% of the abortions that were provided in the 37 states without total abortion bans.
This report will show that by the end of 2025, the number of brick-and-mortar abortion clinics had declined by 2% compared to March 2024. This net decrease, while small, nevertheless reflects substantial changes or “churn” in abortion access, as many clinics paused or resumed abortion provision or closed or reopened their doors in response to new regulatory, financial and staffing challenges.
The Guttmacher Institute has long tracked the number of brick-and-mortar clinics—physical facilities, often specializing in sexual and reproductive health services—that routinely provide abortion care. As recently as 2020, these facilities were the only way to access clinician-provided abortion care in the United States. That changed in 2021, when the US Food and Drug Administration (FDA) removed the in-person dispensing requirement for mifepristone, one of two drugs used in most medication abortions. Since then, medication abortion provided through telehealth has become increasingly common. Remote provision of abortion is safe and effective, and for those living in abortion-restrictive states, it can be one of the only ways to access clinician-provided care.